RSVpreF3 OA for Prevention of Lower Respiratory Tract Disease due to Respiratory Syncytial Virus in Older Adults

Feb 23, 2023 | Emerging Technology Report

RSVPreF3 OA is an investigational recombinant respiratory syncytial virus antigen vaccine for adults ≥ 60 years of age.

If you have a Hayes login, click here to view the full report on the Knowledge Center.